148 related articles for article (PubMed ID: 26668934)
1. Lightening up Ruthenium Complexes to Fight Cancer?
Mari C; Gasser G
Chimia (Aarau); 2015; 69(4):176-81. PubMed ID: 26668934
[TBL] [Abstract][Full Text] [Related]
2. Relevance of the electron transfer pathway in photodynamic activity of Ru(II) polypyridyl complexes containing 4,7-diphenyl-1,10-phenanthroline ligands under normoxic and hypoxic conditions.
Mazuryk O; Janczy-Cempa E; Łagosz J; Rutkowska-Zbik D; Machnicka A; Krasowska A; Pietrzyk P; Stochel G; Brindell M
Dalton Trans; 2022 Feb; 51(5):1888-1900. PubMed ID: 35018930
[TBL] [Abstract][Full Text] [Related]
3. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.
Heinemann F; Karges J; Gasser G
Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879
[TBL] [Abstract][Full Text] [Related]
4. The Development of Ru(II)-Based Photoactivated Chemotherapy Agents.
Chen Y; Bai L; Zhang P; Zhao H; Zhou Q
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577150
[TBL] [Abstract][Full Text] [Related]
5. Detailed Biological Profiling of a Photoactivated and Apoptosis Inducing pdppz Ruthenium(II) Polypyridyl Complex in Cancer Cells.
Cloonan SM; Elmes RB; Erby M; Bright SA; Poynton FE; Nolan DE; Quinn SJ; Gunnlaugsson T; Williams DC
J Med Chem; 2015 Jun; 58(11):4494-505. PubMed ID: 25961430
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, structure, DNA-binding properties, and cytotoxicity of ruthenium(II) polypyridyl complexes.
Liu YJ; Zeng CH; Yao JH; Wu FH; He LX; Huang HL
Chem Biodivers; 2010 Jul; 7(7):1770-83. PubMed ID: 20658665
[TBL] [Abstract][Full Text] [Related]
7. Ruthenium(II) polypyridyl complexes as mitochondria-targeted two-photon photodynamic anticancer agents.
Liu J; Chen Y; Li G; Zhang P; Jin C; Zeng L; Ji L; Chao H
Biomaterials; 2015 Jul; 56():140-53. PubMed ID: 25934287
[TBL] [Abstract][Full Text] [Related]
8. Ruthenium-Based Photoactivated Chemotherapy.
Bonnet S
J Am Chem Soc; 2023 Nov; 145(43):23397-23415. PubMed ID: 37846939
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the In Vitro and In Vivo Efficacy of Ruthenium Polypyridyl Compounds against Breast Cancer.
Lenis-Rojas OA; Roma-Rodrigues C; Fernandes AR; Carvalho A; Cordeiro S; Guerra-Varela J; Sánchez L; Vázquez-García D; López-Torres M; Fernández A; Fernández JJ
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445620
[TBL] [Abstract][Full Text] [Related]
10. Ruthenium-based PACT agents based on bisquinoline chelates: synthesis, photochemistry, and cytotoxicity.
Busemann A; Flaspohler I; Zhou XQ; Schmidt C; Goetzfried SK; van Rixel VHS; Ott I; Siegler MA; Bonnet S
J Biol Inorg Chem; 2021 Sep; 26(6):667-674. PubMed ID: 34378103
[TBL] [Abstract][Full Text] [Related]
11. Boosting type I process of Ru(II) compounds by changing tetrazole ligand for enhanced photodynamic therapy against lung cancer.
Zhang X; Huang X; Xie A; Zhang X; Deng J; Zou D; Zou J
J Inorg Biochem; 2020 Nov; 212():111236. PubMed ID: 32889130
[TBL] [Abstract][Full Text] [Related]
12. Dinuclear double-stranded metallosupramolecular ruthenium complexes: potential anticancer drugs.
Hotze AC; Kariuki BM; Hannon MJ
Angew Chem Int Ed Engl; 2006 Jul; 45(29):4839-42. PubMed ID: 16802394
[No Abstract] [Full Text] [Related]
13. Recent developments in ruthenium anticancer drugs.
Levina A; Mitra A; Lay PA
Metallomics; 2009 Nov; 1(6):458-70. PubMed ID: 21305154
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of action of Ru(ii) polypyridyl complexes in living cells upon light irradiation.
Jakubaszek M; Goud B; Ferrari S; Gasser G
Chem Commun (Camb); 2018 Nov; 54(93):13040-13059. PubMed ID: 30398487
[TBL] [Abstract][Full Text] [Related]
15. Protein binding and anticancer activity studies of ruthenium(II) polypyridyl complexes toward BEL-7402 cells.
Lai SH; Li W; Yao JH; Han BJ; Jiang GB; Zhang C; Zeng CC; Liu YJ
J Photochem Photobiol B; 2016 May; 158():39-48. PubMed ID: 26945645
[TBL] [Abstract][Full Text] [Related]
16. Strained ruthenium complexes are potent light-activated anticancer agents.
Howerton BS; Heidary DK; Glazer EC
J Am Chem Soc; 2012 May; 134(20):8324-7. PubMed ID: 22553960
[TBL] [Abstract][Full Text] [Related]
17. Recent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumors.
Thangavel P; Viswanath B; Kim S
Int J Nanomedicine; 2017; 12():2749-2758. PubMed ID: 28435255
[TBL] [Abstract][Full Text] [Related]
18. Light-activated ruthenium complexes photobind DNA and are cytotoxic in the photodynamic therapy window.
Wachter E; Heidary DK; Howerton BS; Parkin S; Glazer EC
Chem Commun (Camb); 2012 Oct; 48(77):9649-51. PubMed ID: 22908094
[TBL] [Abstract][Full Text] [Related]
19. Fusion of photodynamic therapy and photoactivated chemotherapy: a novel Ru(II) arene complex with dual activities of photobinding and photocleavage toward DNA.
Chen Y; Lei W; Jiang G; Hou Y; Li C; Zhang B; Zhou Q; Wang X
Dalton Trans; 2014 Nov; 43(41):15375-84. PubMed ID: 25188424
[TBL] [Abstract][Full Text] [Related]
20. Strained, Photoejecting Ru(II) Complexes that are Cytotoxic Under Hypoxic Conditions.
Roque J; Havrylyuk D; Barrett PC; Sainuddin T; McCain J; Colón K; Sparks WT; Bradner E; Monro S; Heidary D; Cameron CG; Glazer EC; McFarland SA
Photochem Photobiol; 2020 Mar; 96(2):327-339. PubMed ID: 31691282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
